HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

High levels of peripheral blood NK cells in women suffering from recurrent spontaneous abortion are reverted from high-dose intravenous immunoglobulins.

AbstractPROBLEM:
To determine the levels of peripheral blood natural killer (NK) cells in healthy women and recurrent aborters, and the effect of intravenous immunoglobulins (IVIGs) on these levels.
METHOD OF STUDY:
A total of 659 women were evaluated for NK cells by means of flow cytofluorimetry: 42 non-pregnant healthy women, 394 non-pregnant recurrent spontaneous abortion (RSA) women, 36 pregnant healthy women and 187 pregnant RSA women. Fifty-four of the pregnant RSA women were treated with IVIG; in 18 of them NK cells were measured immediately before and after the very first IVIG infusion (0.5 g/kg body weight).
RESULTS:
Blood NK cell results were increased in RSA pregnant/non-pregnant women, and significantly reduced by IVIG, even after the very first infusion. In RSA pregnant women treated by means of IVIG therapy, 92.3% success rate was observed.
CONCLUSIONS:
High levels of NK cells are detected in women affected by RSA. IVIGs are capable of decreasing them with a short- and long-term efficacy, allowing having a very high success rate of pregnancies in RSA women.
AuthorsRoberto Perricone, Gioia Di Muzio, Carlo Perricone, Roberto Giacomelli, Domenico De Nardo, Luigi Fontana, Caterina De Carolis
JournalAmerican journal of reproductive immunology (New York, N.Y. : 1989) (Am J Reprod Immunol) Vol. 55 Issue 3 Pg. 232-9 (Mar 2006) ISSN: 1046-7408 [Print] Denmark
PMID16451358 (Publication Type: Comparative Study, Journal Article)
Chemical References
  • Immunoglobulins, Intravenous
Topics
  • Abortion, Habitual (blood, drug therapy, immunology)
  • Birth Rate
  • Dose-Response Relationship, Immunologic
  • Female
  • Humans
  • Immunoglobulins, Intravenous (therapeutic use)
  • Killer Cells, Natural (drug effects, immunology)
  • Pregnancy

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: